Norske Skog Valuation
Is 0BQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 0BQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 0BQ (€3.19) wird unter unserer Schätzung des Fair Value (€4.43) gehandelt.
Deutlich unter dem Marktwert: 0BQ unter dem beizulegenden Zeitwert gehandelt wird, jedoch nicht um einen signifikanten Betrag.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0BQ?
Other financial metrics that can be useful for relative valuation.
| What is 0BQ's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | kr2.92b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | 2.7x |
| PEG Ratio | 0.2x |
Price to Earnings Ratio vs Peers
How does 0BQ's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 13.6x | ||
UZU Uzin Utz | 11.1x | 6.7% | €250.2m |
2HRA H&R GmbH KGaA | 17.1x | 23.9% | €180.5m |
ACT AlzChem Group | 11.8x | 12.6% | €408.1m |
SIM0 SIMONA | 14.4x | n/a | €411.0m |
0BQ Norske Skog | 6.1x | 35.7% | €2.9b |
Price-To-Earnings gegen Gleichaltrige: 0BQ ist ein guter Wert, wenn man sein Price-To-Earnings Verhältnis (3.3x) mit dem Durchschnitt der anderen Unternehmen (11.2x) vergleicht.
Price to Earnings Ratio vs Industry
How does 0BQ's PE Ratio compare vs other companies in the European Forestry Industry?
Price-To-Earnings gegen Industrie: 0BQ ist aufgrund seines Price-To-Earnings Verhältnisses (6.5x) im Vergleich zum European Forestry Branchendurchschnitt (8.2x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is 0BQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 6.1x |
| Fair PE Ratio | 17.8x |
PM vs. Fair Ratio: 0BQ ist ein guter Wert auf der Grundlage des Verhältnisses Price-To-Earnings (3.3x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (14.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €2.90 | €4.02 +38.6% | 20.2% | €5.16 | €3.44 | n/a | 3 |
| Mar ’25 | €3.23 | €4.70 +45.6% | 17.7% | €5.28 | €3.52 | n/a | 3 |
| Feb ’25 | €3.16 | €4.97 +57.4% | 8.3% | €5.26 | €4.39 | n/a | 3 |
| Jan ’25 | €3.61 | €5.64 +56.1% | 25.5% | €7.61 | €4.23 | n/a | 3 |
| Dec ’24 | €3.42 | €5.64 +64.8% | 25.5% | €7.61 | €4.23 | n/a | 3 |
| Nov ’24 | €3.42 | €6.49 +89.7% | 12.3% | €7.62 | €5.93 | n/a | 3 |
| Oct ’24 | €4.04 | €7.33 +81.7% | 10.4% | €8.08 | €6.29 | n/a | 3 |
| Sep ’24 | €3.60 | €7.33 +104.0% | 10.4% | €8.08 | €6.29 | n/a | 3 |
| Aug ’24 | €3.95 | €7.33 +85.9% | 10.4% | €8.08 | €6.29 | n/a | 3 |
| Jul ’24 | €3.54 | €7.55 +113.6% | 9.6% | €8.55 | €6.84 | n/a | 3 |
| Jun ’24 | €3.41 | €7.85 +130.4% | 10.1% | €8.41 | €6.73 | n/a | 3 |
| May ’24 | €3.93 | €7.97 +102.7% | 10.1% | €8.54 | €6.83 | n/a | 3 |
| Apr ’24 | €4.97 | €9.53 +91.6% | 15.7% | €10.89 | €7.45 | €2.81 | 3 |
| Mar ’24 | €6.02 | €9.53 +58.4% | 15.7% | €10.89 | €7.45 | €3.23 | 3 |
| Feb ’24 | €6.14 | €9.53 +55.3% | 15.7% | €10.89 | €7.45 | €3.16 | 3 |
| Jan ’24 | €6.30 | €9.01 +43.0% | 10.1% | €9.65 | €7.72 | €3.61 | 3 |
| Dec ’23 | €5.53 | €9.01 +63.1% | 10.1% | €9.65 | €7.72 | €3.42 | 3 |
| Nov ’23 | €5.97 | €9.01 +51.1% | 10.1% | €9.65 | €7.72 | €3.42 | 3 |
| Oct ’23 | €5.04 | €8.77 +74.1% | 9.1% | €9.75 | €7.80 | €4.04 | 3 |
| Sep ’23 | €6.80 | €8.77 +29.1% | 9.1% | €9.75 | €7.80 | €3.60 | 3 |
| Aug ’23 | €6.79 | €8.77 +29.3% | 9.1% | €9.75 | €7.80 | €3.95 | 3 |
| Jul ’23 | €5.15 | €8.27 +60.7% | 5.4% | €8.59 | €7.64 | €3.54 | 3 |
| Jun ’23 | €5.69 | €8.46 +48.8% | 5.4% | €8.79 | €7.81 | €3.41 | 3 |
| May ’23 | €5.20 | €8.46 +62.7% | 5.7% | €9.14 | €8.12 | €3.93 | 3 |
| Apr ’23 | €5.40 | €8.63 +59.8% | 5.7% | €9.32 | €8.28 | €4.97 | 3 |
Analysten-Prognose: Das Kursziel liegt um mehr als 20% über dem aktuellen Aktienkurs, aber die Analysten liegen nicht in einem statistisch sicheren Bereich der Übereinstimmung.